december 12, 2024
lotuskringpoeldijk
DNA / Isotypes / Pcr Kits / Peptides / Ria Kits / Test Kits

Auto-reactivity in opposition to intestine bacterial peptides in sufferers

Natashadoor Natasha

Prognostic Influence of B-Sort Natriuretic Peptide on Lengthy-Time period Scientific Outcomes in Sufferers with Non-ST-Phase Elevation Acute Myocardial Infarction With out Creatine Kinase Elevation

Though B-type natriuretic peptide (BNP) has steadily gained recognition as an indicator in danger stratification for sufferers with acute myocardial infarction (AMI), the prognostic impression on long-term scientific outcomes in sufferers with non-ST-segment elevation acute myocardial infarction (NSTEMI) with out creatine kinase (CK) elevation stays unclear.This potential multicenter research assessed 3,283 consecutive sufferers with AMI admitted to 28 establishments in Japan between 2012 and 2014.

 We analyzed 218 sufferers with NSTEMI with out CK elevation (NSTEMI-CK) for whom BNP was obtainable. Within the NSTEMI-CK group, sufferers had been assigned to high- and low-BNP teams in keeping with BNP values (cut-off BNP, 100 pg/mL). The main endpoint was outlined as a composite of all-cause demise, non-fatal myocardial infarction, non-fatal stroke, cardiac failure, and pressing revascularization for unstable angina as much as Three years.

Major endpoints had been noticed in 60 (33.3%) occasions amongst sufferers with NSTEMI-CK. Kaplan-Meier evaluation revealed a considerably greater occasion charge for main endpoints amongst sufferers with excessive BNP (log-rank P < 0.001). After adjusting for covariates, the next BNP stage was considerably related with long-term scientific outcomes in NSTEMI-CK (adjusted hazard ratio, 4.86; 95% confidence interval, 2.18-12.44; P < 0.001).The BNP focus is related to antagonistic long-term scientific outcomes amongst sufferers with NSTEMI-CK who’re thought-about low danger. Cautious scientific administration could also be warranted for secondary prevention in sufferers with NSTEMI-CK with excessive BNP ranges.

lotuskringpoeldijk
lotuskringpoeldijk

TAT peptide
TP1451-1mg 1mg Ask for price
Description: TAT peptide

TAT peptide
TP1451-50mg 50mg Ask for price
Description: TAT peptide

TAT peptide
TP1451-5mg 5mg Ask for price
Description: TAT peptide

TAT peptide
MBS5763704-10mg 10mg
EUR 765

TAT peptide
MBS5763704-1mg 1mg
EUR 190

TAT peptide
MBS5763704-5mg 5mg
EUR 485

TAT peptide
MBS5763704-5x10mg 5x10mg
EUR 3305

Peptide T
057-01 5 mg
EUR 140.4

FGL Peptide
073-36 100 μg
EUR 214.92

APK peptide
076-81 200 μg
EUR 199.8

NEF peptide
076-83 500 μg
EUR 140.4

SHA peptide
076-84 500 μg
EUR 177.12

YSY peptide
076-86 100 μg
EUR 230.04

Peptide E / 3200-Dalton Adrenal Enkephalin-Containing Peptide (Bovine)
024-57 200 μg
EUR 86.4

PSTAIR Peptide
070-61 500 μg
EUR 129.6

PGMtide Peptide
040-69 100 μg
EUR 316.44

Adjuvant Peptide
070-05 500 μg
EUR 36.72

Peptide-epsilon
058-22 500 μg
EUR 114.48

Delicious Peptide
070-21 5 mg
EUR 160.92

proSex peptide (20-55)
040-30 100 μg
EUR 355.32

proSex peptide (28-55)
040-31 100 μg
EUR 282.96

proSex peptide (40-55)
040-32 100 μg
EUR 214.92

Bombinin-Like Peptide 1 amide / prepro-Bombinin-Like Peptide (44-70) amide / prepro-Bombinin-Like Peptide (107-133) amide
007-60 100 μg
EUR 214.92

Peptide F-9
038-06 200 μg
EUR 58.32

Sturgeon Peptide (137-158)
021-94 100 μg
EUR 177.12

Peptide Lv (Rat)
008-73 100 μg
EUR 469.8

NGR Peptide 1
025-74 200 μg
EUR 184.68

Anorexigenic Peptide
070-10 5 mg
EUR 86.4

GnRH Associated Peptide (GAP) (1-13) / GnRH Precursor Peptide (14-26) (Human)
029-03 500 μg
EUR 114.48

GnRH Associated Peptide (GAP) (1-24) / GnRH Precursor Peptide (14-37) (Human)
029-04 100 μg
EUR 114.48

GnRH Associated Peptide (GAP) (1-53) / GnRH Precursor Peptide (14-66) (Human)
029-05 20 μg
EUR 267.84

GnRH Associated Peptide (GAP) (25-53) / GnRH Precursor Peptide (38-66) (Human)
029-06 100 μg
EUR 114.48

Bid BH3 peptide
025-87 1 mg
EUR 170.64

AF-16 Peptide
033-44 200 μg
EUR 214.92

Peptide Lv (Human)
008-71 100 μg
EUR 405

Peptide Lv (Mouse)
008-72 100 μg
EUR 469.8

GnRH Associated Peptide (GAP) (1-13) / Gn-RH Precursor Peptide (14-26) (Rat)
029-08 200 μg
EUR 64.8

Peptide B (Bovine)
024-56 200 μg
EUR 81

Peptide F (Bovine)
024-58 200 μg
EUR 114.48

ExE peptide M3mP6
064-33 200 μg
EUR 244.08

PLP Peptide (103-116) (Bovine)
070-14 5 mg
EUR 140.4

FMRF-Like Peptide
047-32 1 mg
EUR 27

Joining Peptide (Rat)
047-91 200 μg
EUR 160.92

Growth Hormone-Releasing Peptide-Related Peptide-1 (fGRP-RP-1) (Frog)
048-80 500 μg
EUR 177.12

Growth Hormone-Releasing Peptide-Related Peptide-2 (fGRP-RP-2) (Frog)
048-81 200 μg
EUR 214.92

Growth Hormone-Releasing Peptide-Related Peptide-3 (fGRP-RP-3) (Frog)
048-82 200 μg
EUR 214.92

Peptide T (4-8)
057-04 500 μg
EUR 64.8

Peptide T (5-8)
057-05 500 μg
EUR 64.8

Vasonatrin Peptide (VNP)
005-47 200 μg
EUR 214.92

Opioid Peptide Library
L-002 58 peptides
EUR 2691.36

Peptide Histidine Isoleucine 27 (PHI-27) / Porcine Intestinal Peptide (Porcine)
064-01 200 μg
EUR 108

Heparin Binding Peptide
025-47 500 μg
EUR 102.6

Gastrin Related Peptide
027-09 5 mg
EUR 73.44

PGMtide Control Peptide
040-70 100 μg
EUR 316.44

Growth Blocking Peptide
046-92 100 μg
EUR 255.96

Neuron Specific Peptide
047-55 200 μg
EUR 140.4

Obesity Peptide Library
L-003 160 peptides
EUR 7267.32

[D-Ala1]-Peptide T
057-02 5 mg
EUR 282.96

Peptide YY (PYY) (Human)
059-01 200 μg
EUR 119.88

Eledoisin Related Peptide
046-04 5 mg
EUR 58.32

proSex peptide (28-55) - EIA Kit
EK-040-31 96 wells
EUR 603.72

Peptide F 1 (Lobster)
047-62 500 μg
EUR 73.44

Morphine Tolerance Peptide
050-13 1 mg
EUR 102.6

Phosphate Acceptor Peptide
058-24 500 μg
EUR 73.44

Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human)
064-07 200 μg
EUR 114.48

Peptide I / pro-Histine-Rich Basic Peptide (HRBP) (1-26) (Aplysia brasiliana)
047-39 200 μg
EUR 444.96

Peptide II / pro-Histine-Rich Basic Peptide (HRBP) (29-40) (Aplysia brasiliana)
047-40 500 μg
EUR 214.92

Peptide I / pro-Histine-Rich Basic Peptide (HRBP) (1-26) (Aplysia californica)
047-42 200 μg
EUR 444.96

Peptide II / pro-Histine-Rich Basic Peptide (HRBP) (29-40) (Aplysia californica)
047-43 500 μg
EUR 214.92

FGL Peptide - Cy3 Labeled
FC3-073-36 1 nmol
EUR 672.84

FGL Peptide - Cy5 Labeled
FC5-073-36 1 nmol
EUR 756

FGL Peptide - FAM Labeled
FG-073-36A 1 nmol
EUR 405

Pedal Peptide (Pep) (Aplysia)
047-61 500 μg
EUR 177.12

ExE peptide M3mP6 mutant
064-35 200ug
EUR 234.36

ExE peptide M3mP6 mutant
064-37 200ug
EUR 234.36

FGL Peptide - FITC Labeled
FG-073-36B 1 nmol
EUR 405

AF-16 Peptide - Antibody
H-033-44 100 μl
EUR 336.96

Schizophrenia Related Peptide
047-79 5 mg
EUR 44.28

Insulin B (22-25) Peptide
035-08 5 mg
EUR 86.4

Eosinophilotactic Peptide (AGSE)
070-28 5 mg
EUR 27

Eosinophilotactic Peptide (VGSE)
070-29 5 mg
EUR 27

Cell Penetrating ARF Peptide (26-44)
068-56 500 μg
EUR 640.44

Peptide Histidine Isoleucine 27 (PHI-27) / Porcine Intestinal Peptide (Porcine) - RIA Kit
RK-064-01 125 tubes
EUR 932.04

FGL Peptide - Biotin Labeled
B-073-36 20 μg
EUR 405

Peptide F (Bovine) - Antibody
H-024-58 50 μl
EUR 238.68

Brain Peptide (Bees) Library
L-007 51 peptides
EUR 6456.24

TAT Derivative, R9-Tat
068-27 500 μg
EUR 370.44

Gastrointestinal Peptide Library
L-006 200 peptides
EUR 7267.32

Peptide R / CXCR4 Antagonist
030-25 200 μg
EUR 203.04

PGMtide Peptide - Cy3 Labeled
FC3-040-69 1 nmol
EUR 925.56

PGMtide Peptide - FAM Labeled
FG-040-69A 5 nmol
EUR 537.84

[D-Arg14, D-Arg15]-MGF Peptide amide / C-terminal peptide of IGF-1 Ec amide
033-34 100 μg
EUR 177.12

Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - Antibody
H-064-07 50 μl
EUR 238.68

[D-Ala1]-Peptide T amide
057-03 500 μg
EUR 140.4

Peptide F (Bovine) - RIA Kit
RK-024-58 125 tubes
EUR 932.04

Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - RIA Kit
RK-064-07 125 tubes
EUR 932.04

Catch-Relaxing Peptide (CARP)
047-20 1 mg
EUR 199.8

Calmodulin Binding Peptide 1
070-17 20 μg
EUR 214.92

FGL Peptide - Rhodamine Labeled
FR-073-36 1 nmol
EUR 537.84

Peptide-Depleted Plasma (Rat)
MB-099-02 2 ml
EUR 119.88

Glycogenolysis-Inhibiting Peptide
023-63 500 μg
EUR 177.12

Anti-Inflammatory Peptide 1
004-01 200 μg
EUR 27

Anti-Inflammatory Peptide 2
004-02 200 μg
EUR 27

Anti-Inflammatory Peptide 3
004-03 200 μg
EUR 27

Urokinase-Derived Peptide A6
025-12 500 μg
EUR 129.6

Cruzioseptins, antibacterial peptides from Cruziohyla calcarifer pores and skin, as promising leishmanicidal brokers

Screenings of pure merchandise have considerably contributed to the invention of novel leishmanicidal brokers. On this research, three identified cruzioseptins-antibacterial peptides from Cruziohyla calcarifer skin-were synthesized and evaluated in opposition to promastigotes and amastigotes levels of Leishmania (L.) amazonensis and L. (V.) braziliensis. EC50 ranged from 9.17 µM to 74.82 µM, being cruzioseptin-1 probably the most energetic and selective compound, with selectivity index > 10 for each promastigotes and amastigotes of L. (V.) braziliensis.

In vitro infections incubated with cruzioseptins at 50 µM confirmed as much as ∼86% discount within the amastigote quantity. Cruzioseptins had been capable of destabilize the parasite’s cell membrane, permitting the incorporation of a DNA-fluorescent dye. Our information additionally demonstrated that hydrophobicity and cost look like advantageous options for enhancing parasiticidal exercise. Antimicrobial cruzioseptins are appropriate candidates and different molecules that deserve additional in vivo investigation specializing in the event of novel antileishmanial therapies.

Examine on Adenovirus An infection in vitro with Nanoself-Assembling Peptide as Scaffolds for 3D Tradition

Objective: To assemble a three-dimensional (3D) tradition mannequin of adenovirus in vitro utilizing the nanoself-assembling peptide RADA16-I as a 3D cell tradition scaffold mixed with virology experimental expertise to offer a novel analysis technique for virus isolation and tradition, pathogenesis analysis, antiviral drug screening and vaccine preparation.

Strategies: The nanoself-assembling peptide RADA16-I used to be used as a 3D scaffold materials for 293T cell tradition, and adenovirus was cultured within the cells. The expansion, morphological traits and pathological results of 3D-cultured 293T cells after adenovirus an infection had been noticed with an inverted microscope and MTS. The proliferation of adenovirus in 293T cells was noticed by TEM and detected by qPCR. The degrees of TNF-α and IL-Eight secreted by adenovirus-infected 293T cells within the RADA16-I 3D tradition system had been detected by ELISA.

Outcomes: The 293T cells grew properly within the RADA16-I 3D tradition system for a protracted time frame. The adenovirus an infection continued for a very long time with a number of proliferation peaks, which carefully resembled these of in vivo infections. The adenovirus virions amplified within the 3D system remained infectious. There have been a number of secretion peaks of TNF-α and IL-Eight secretion ranges in adenovirus-infected 293T cells cultured in 3D tradition methods.

Conclusion: The nanoself-assembling peptide RADA16-I can be utilized as a 3D scaffold for adenovirus isolation, tradition and analysis. The 3D tradition system exhibits extra lifelike in vivo results than two-dimensional (2D) tradition.

Auto-reactivity in opposition to intestine bacterial peptides in sufferers with late-onset diabetes

The depletion of intestine mucosal barrier allows publicity of intestine microbes/intestine microbial merchandise to the host mucosal immunity which can enhance the chance of metabolic/inflammatory problems. These immune responses can result in the event of gentle autoimmunity to metabolic peptides coming from intestine micro organism and will lead to metabolic ailments like late-onset diabetes (LOD).

 Within the current research, we recognized host sera cross-reactivity with intestine bacterial peptides much like host proteins. The interplay between diabetic sera and intestine peptides was detected by enzyme-linked immunosorbent assay (ELISA) and outcomes had been confirmed utilizing floor plasmon resonance (SPR). The ELISA assay confirmed the next stage of serum cross-reactivity in LOD sufferers as in comparison with non-diabetic controls in opposition to three peptides (P-5, P-9, and P-13). SPR evaluation confirmed binding-affinity in opposition to P-5 and P-13. Additionally, a big correlation was noticed between inflammatory markers and P-5. This research demonstrates that intestine well being is vital not just for intestinal ailments but in addition for a number of late-onset ailments, like, diabetes.

IRF4 Blocking Peptide
20-abx062142
  • Ask for price
  • Ask for price
  • 1 mg
  • 5 mg

IRF4 Blocking Peptide
DF6198-BP 1mg
EUR 234

IRF4 Blocking Peptide
AF4776-BP 1mg
EUR 234

IRF4 Blocking Peptide
AF0692-BP 1mg
EUR 234

IRF4 Blocking Peptide
MBS8209654-1mg 1mg
EUR 190

IRF4 Blocking Peptide
MBS8209654-5mg 5mg
EUR 345

IRF4 Blocking Peptide
MBS8209654-5x5mg 5x5mg
EUR 1465

IRF4 Blocking Peptide
MBS428901-01mg 0.1mg
EUR 230

IRF4 Blocking Peptide
MBS9615069-1mg 1mg
EUR 380

IRF4 Blocking Peptide
MBS9615069-5x1mg 5x1mg
EUR 1650

IRF4 Blocking Peptide
MBS9616765-1mg 1mg
EUR 380

IRF4 Blocking Peptide
MBS9616765-5x1mg 5x1mg
EUR 1650

IRF4 Blocking Peptide
MBS9625574-1mg 1mg
EUR 380

IRF4 Blocking Peptide
MBS9625574-5x1mg 5x1mg
EUR 1650

IRF4 Immunizing Peptide
MBS427645-01mg 0.1mg
EUR 225

IRF4 Peptide - middle region
MBS3228901-01mg 0.1mg
EUR 180

IRF4 Peptide - middle region
MBS3228901-5x01mg 5x0.1mg
EUR 730

AAP32669-100UG - IRF4 Peptide
AAP32669-100UG 100ug
EUR 99

AAP38154-100UG - IRF4 Peptide
AAP38154-100UG 100ug
EUR 99

IRF4 Peptide - N-terminal region
MBS3248213-01mg 0.1mg
EUR 180

IRF4 Peptide - N-terminal region
MBS3248213-5x01mg 5x0.1mg
EUR 730

IRF4 Antibody (Center) Blocking peptide
MBS9219288-INQUIRE INQUIRE Ask for price

Mast Cell-Degranulating Peptide (MCD Peptide) / Peptide 401
004-04 100 μg
EUR 140.4

AAP38155-100UG - IRF4 Peptide - middle region
AAP38155-100UG 100ug
EUR 99

Peptide T
057-01 5 mg
EUR 140.4

FGL Peptide
073-36 100 μg
EUR 214.92

APK peptide
076-81 200 μg
EUR 199.8

NEF peptide
076-83 500 μg
EUR 140.4

SHA peptide
076-84 500 μg
EUR 177.12

YSY peptide
076-86 100 μg
EUR 230.04

Peptide E / 3200-Dalton Adrenal Enkephalin-Containing Peptide (Bovine)
024-57 200 μg
EUR 86.4

PSTAIR Peptide
070-61 500 μg
EUR 129.6

PGMtide Peptide
040-69 100 μg
EUR 316.44

Adjuvant Peptide
070-05 500 μg
EUR 36.72

Peptide-epsilon
058-22 500 μg
EUR 114.48

Delicious Peptide
070-21 5 mg
EUR 160.92

proSex peptide (20-55)
040-30 100 μg
EUR 355.32

proSex peptide (28-55)
040-31 100 μg
EUR 282.96

proSex peptide (40-55)
040-32 100 μg
EUR 214.92

Bombinin-Like Peptide 1 amide / prepro-Bombinin-Like Peptide (44-70) amide / prepro-Bombinin-Like Peptide (107-133) amide
007-60 100 μg
EUR 214.92

Peptide F-9
038-06 200 μg
EUR 58.32

Sturgeon Peptide (137-158)
021-94 100 μg
EUR 177.12

Peptide Lv (Rat)
008-73 100 μg
EUR 469.8

NGR Peptide 1
025-74 200 μg
EUR 184.68

Anorexigenic Peptide
070-10 5 mg
EUR 86.4

GnRH Associated Peptide (GAP) (1-13) / GnRH Precursor Peptide (14-26) (Human)
029-03 500 μg
EUR 114.48

GnRH Associated Peptide (GAP) (1-24) / GnRH Precursor Peptide (14-37) (Human)
029-04 100 μg
EUR 114.48

GnRH Associated Peptide (GAP) (1-53) / GnRH Precursor Peptide (14-66) (Human)
029-05 20 μg
EUR 267.84

GnRH Associated Peptide (GAP) (25-53) / GnRH Precursor Peptide (38-66) (Human)
029-06 100 μg
EUR 114.48

Bid BH3 peptide
025-87 1 mg
EUR 170.64

AF-16 Peptide
033-44 200 μg
EUR 214.92

Peptide Lv (Human)
008-71 100 μg
EUR 405

Peptide Lv (Mouse)
008-72 100 μg
EUR 469.8

GnRH Associated Peptide (GAP) (1-13) / Gn-RH Precursor Peptide (14-26) (Rat)
029-08 200 μg
EUR 64.8

Peptide B (Bovine)
024-56 200 μg
EUR 81

Peptide F (Bovine)
024-58 200 μg
EUR 114.48

ExE peptide M3mP6
064-33 200 μg
EUR 244.08

PLP Peptide (103-116) (Bovine)
070-14 5 mg
EUR 140.4

FMRF-Like Peptide
047-32 1 mg
EUR 27

Joining Peptide (Rat)
047-91 200 μg
EUR 160.92

Growth Hormone-Releasing Peptide-Related Peptide-1 (fGRP-RP-1) (Frog)
048-80 500 μg
EUR 177.12

Growth Hormone-Releasing Peptide-Related Peptide-2 (fGRP-RP-2) (Frog)
048-81 200 μg
EUR 214.92

Growth Hormone-Releasing Peptide-Related Peptide-3 (fGRP-RP-3) (Frog)
048-82 200 μg
EUR 214.92

Peptide T (4-8)
057-04 500 μg
EUR 64.8

Peptide T (5-8)
057-05 500 μg
EUR 64.8

Vasonatrin Peptide (VNP)
005-47 200 μg
EUR 214.92

Opioid Peptide Library
L-002 58 peptides
EUR 2691.36

Peptide Histidine Isoleucine 27 (PHI-27) / Porcine Intestinal Peptide (Porcine)
064-01 200 μg
EUR 108

Heparin Binding Peptide
025-47 500 μg
EUR 102.6

Gastrin Related Peptide
027-09 5 mg
EUR 73.44

PGMtide Control Peptide
040-70 100 μg
EUR 316.44

Growth Blocking Peptide
046-92 100 μg
EUR 255.96

Neuron Specific Peptide
047-55 200 μg
EUR 140.4

Obesity Peptide Library
L-003 160 peptides
EUR 7267.32

[D-Ala1]-Peptide T
057-02 5 mg
EUR 282.96

Peptide YY (PYY) (Human)
059-01 200 μg
EUR 119.88

Eledoisin Related Peptide
046-04 5 mg
EUR 58.32

proSex peptide (28-55) - EIA Kit
EK-040-31 96 wells
EUR 603.72

Peptide F 1 (Lobster)
047-62 500 μg
EUR 73.44

Morphine Tolerance Peptide
050-13 1 mg
EUR 102.6

Phosphate Acceptor Peptide
058-24 500 μg
EUR 73.44

Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human)
064-07 200 μg
EUR 114.48

Peptide I / pro-Histine-Rich Basic Peptide (HRBP) (1-26) (Aplysia brasiliana)
047-39 200 μg
EUR 444.96

Peptide II / pro-Histine-Rich Basic Peptide (HRBP) (29-40) (Aplysia brasiliana)
047-40 500 μg
EUR 214.92

Peptide I / pro-Histine-Rich Basic Peptide (HRBP) (1-26) (Aplysia californica)
047-42 200 μg
EUR 444.96

Peptide II / pro-Histine-Rich Basic Peptide (HRBP) (29-40) (Aplysia californica)
047-43 500 μg
EUR 214.92

FGL Peptide - Cy3 Labeled
FC3-073-36 1 nmol
EUR 672.84

FGL Peptide - Cy5 Labeled
FC5-073-36 1 nmol
EUR 756

FGL Peptide - FAM Labeled
FG-073-36A 1 nmol
EUR 405

Pedal Peptide (Pep) (Aplysia)
047-61 500 μg
EUR 177.12

ExE peptide M3mP6 mutant
064-35 200ug
EUR 234.36

ExE peptide M3mP6 mutant
064-37 200ug
EUR 234.36

FGL Peptide - FITC Labeled
FG-073-36B 1 nmol
EUR 405

AF-16 Peptide - Antibody
H-033-44 100 μl
EUR 336.96

Schizophrenia Related Peptide
047-79 5 mg
EUR 44.28

Insulin B (22-25) Peptide
035-08 5 mg
EUR 86.4

Eosinophilotactic Peptide (AGSE)
070-28 5 mg
EUR 27

Eosinophilotactic Peptide (VGSE)
070-29 5 mg
EUR 27

Cell Penetrating ARF Peptide (26-44)
068-56 500 μg
EUR 640.44

Peptide Histidine Isoleucine 27 (PHI-27) / Porcine Intestinal Peptide (Porcine) - RIA Kit
RK-064-01 125 tubes
EUR 932.04

FGL Peptide - Biotin Labeled
B-073-36 20 μg
EUR 405

Peptide F (Bovine) - Antibody
H-024-58 50 μl
EUR 238.68

Brain Peptide (Bees) Library
L-007 51 peptides
EUR 6456.24

Gastrointestinal Peptide Library
L-006 200 peptides
EUR 7267.32

Peptide R / CXCR4 Antagonist
030-25 200 μg
EUR 203.04

PGMtide Peptide - Cy3 Labeled
FC3-040-69 1 nmol
EUR 925.56

PGMtide Peptide - FAM Labeled
FG-040-69A 5 nmol
EUR 537.84

[D-Arg14, D-Arg15]-MGF Peptide amide / C-terminal peptide of IGF-1 Ec amide
033-34 100 μg
EUR 177.12

Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - Antibody
H-064-07 50 μl
EUR 238.68

[D-Ala1]-Peptide T amide
057-03 500 μg
EUR 140.4

Peptide F (Bovine) - RIA Kit
RK-024-58 125 tubes
EUR 932.04

Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - RIA Kit
RK-064-07 125 tubes
EUR 932.04

Catch-Relaxing Peptide (CARP)
047-20 1 mg
EUR 199.8

Calmodulin Binding Peptide 1
070-17 20 μg
EUR 214.92

FGL Peptide - Rhodamine Labeled
FR-073-36 1 nmol
EUR 537.84

Peptide-Depleted Plasma (Rat)
MB-099-02 2 ml
EUR 119.88

Glycogenolysis-Inhibiting Peptide
023-63 500 μg
EUR 177.12

Anti-Inflammatory Peptide 1
004-01 200 μg
EUR 27

Anti-Inflammatory Peptide 2
004-02 200 μg
EUR 27

Anti-Inflammatory Peptide 3
004-03 200 μg
EUR 27

Urokinase-Derived Peptide A6
025-12 500 μg
EUR 129.6

PGMtide Peptide - Biotin Labeled
B-040-69 20 μg
EUR 537.84

Peptide 34 / GPR-54 Agonist
048-94 200 μg
EUR 114.48

FGL Peptide - I-125 Labeled
T-073-36 10 μCi
EUR 1145.88

Peptide-Depleted Plasma (Human)
MB-099-01 2 ml
EUR 119.88

Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - FAM Labeled
FG-064-07A 1 nmol
EUR 336.96

Peptide Histidine Isoleucine 27 (PHI-27) / Porcine Intestinal Peptide (Porcine) - I-125 Labeled
T-064-01 10 μCi
EUR 1145.88

F3 Peptide / HMGN2 Fragment 3
004-12 100 μg
EUR 214.92

Antimicrobial Trp-rich peptide
004-05 100 μg
EUR 140.4

Fibronectin CS1 Peptide (EILDVPST)
025-20 500 μg
EUR 86.4

Myosin Kinase Inhibiting Peptide
058-20 500 μg
EUR 50.76

Peptide YY (PYY) (3-36) (Human)
059-02 200 μg
EUR 102.6

PGMtide Peptide - Rhodamine Labeled
FR-040-69 5 nmol
EUR 604.8

Anti-Angiogenic Peptide Library
L-008A 88 peptides
EUR 6067.44

Peptide YY (PYY) (Human) - Antibody
H-059-01 100 μl
EUR 469.8

Peptide Histidine Isoleucine 27 (PHI-27) / Porcine Intestinal Peptide (Porcine) - Purified IgG Antibody
G-064-01 400 μg
EUR 438.48

Peptide A / p60v-src (137-157)
058-21 500 μg
EUR 135

pro-Opionmelanocortin / J Peptide
022-22 200 μg
EUR 177.12

Cancer-Targeting Peptide Library
L-015 289 peptides
EUR 7253.28

C28 optimized peptide 6 (Human)
073-82 100 μg
EUR 235.44

Kemptide / Phosphate Acceptor Peptide
058-16 500 μg
EUR 36.72

Bioactive Secretory Peptide Library
L-009 1016 peptides
EUR 31350.24

Peptide YY (PYY) (Human) - EIA Kit
EK-059-01 96 wells
EUR 617.76

Peptide YY (PYY) (Human) - RIA Kit
RK-059-01 125 tubes
EUR 814.32

Galanin-Like Peptide (GALP) (Rat)
026-52 100 μg
EUR 282.96

PACAP-Related Peptide (PRP) (Rat)
052-11 200 μg
EUR 86.4

Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - I-125 Labeled
T-064-07 10 μCi
EUR 1145.88

Crustacean Cardioactive Peptide (CCAP)
047-24 500 μg
EUR 86.4

Virus Replication Inhibiting Peptide
070-85 5 mg
EUR 160.92

Pri Peptide from sORF pri RNA
069-77 200 μg
EUR 160.92

Alzheimer Fingerprint Peptide Library
L-011 85 peptides
EUR 6529.68

Annexin A1 Binding Peptide, IF7CRR
025-72 200 μg
EUR 184.68

Galanin-Like Peptide (GALP) (Human)
026-51 100 μg
EUR 230.04

Gastrin Releasing Peptide (GRP) (Rat)
027-32 100 μg
EUR 160.92

FMRF-Like Peptide (Helix aspersa)
047-31 1 mg
EUR 27

Natasha

Bekijk alle berichten van Natasha →

Dit vind je misschien ook leuk

lotuskringpoeldijk

Characterization and Quantitative Willpower of a Various Group of Bacillus subtilis subsp. subtilis NCIB

lotuskringpoeldijk

Antimicrobial resistance of ocular microbes and the function of antimicrobial peptides

lotuskringpoeldijk

Self-Immobilized Putrescine Oxidase Biocatalyst System Engineered with a Metallic

Geef een antwoord

Het e-mailadres wordt niet gepubliceerd.